
    
      The primary objectives of this study are to determine the changes in the lipid profile
      [LDL-C, HDL-C, triglycerides, total cholesterol] and the emerging risk factor, Lp(a), when
      policosanol is added to statin therapy. Additionally, one more primary objective is to
      evaluate the safety of the combination regimen.
    
  